Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
Business Wire•14/08/2026•01:00 ET
0
Whiz Insights
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
* Submission based on favorable efficacy and safety results from Phase 3 VALOR trial
Get started
Create a free account to read the full story.